PLEU15048 / ACCL1333 / CV185-155 / Angela Girvin
Research Question:
Does the drug Apixaban prevent blood clots in children with leukemia or lymphoma?
Basic Study Information
Purpose:
The purpose of this study is to compare the effect of a blood thinning drug called
Apixaban versus no administration of a blood thinning drug, in preventing blood clots
in children with leukemia or lymphoma. Patients must be receiving chemotherapy, including
asparaginase, and have a central line (a catheter inserted for administration of medications
and blood sampling)
Location: University Of Rochester General Clinical Research Center
Lead Researcher (Principal Investigator)
Lead Researcher:
Angela Girvin
Study Contact Information
Study Coordinator: Tina Bowdish
Phone: +1 585-275-9475
Email: tina_bowdish@urmc.rochester.edu
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search